1. Home
  2. RSVR vs YDES Comparison

RSVR vs YDES Comparison

Compare RSVR & YDES Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Reservoir Media Inc.

RSVR

Reservoir Media Inc.

N/A

Current Price

$9.27

Market Cap

642.8M

ML Signal

N/A

YDES

YD Bio Limited Ordinary Shares

N/A

Current Price

$3.76

Market Cap

543.0M

Sector

N/A

ML Signal

N/A

Company Overview

Basic Information
Metric
RSVR
YDES
Founded
2007
2013
Country
United States
Taiwan
Employees
N/A
N/A
Industry
Movies/Entertainment
Sector
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
642.8M
543.0M
IPO Year
2020
2024

Fundamental Metrics

Financial Performance
Metric
RSVR
YDES
Price
$9.27
$3.76
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
$11.50
N/A
AVG Volume (30 Days)
49.7K
356.2K
Earning Date
05-27-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
8.33
N/A
EPS
0.13
N/A
Revenue
$175,664,491.00
N/A
Revenue This Year
$10.95
N/A
Revenue Next Year
$4.16
N/A
P/E Ratio
$71.92
N/A
Revenue Growth
10.69
N/A
52 Week Low
$7.07
$1.70
52 Week High
$13.39
$22.00

Technical Indicators

Market Signals
Indicator
RSVR
YDES
Relative Strength Index (RSI) 42.75 54.41
Support Level $7.31 $2.99
Resistance Level $10.34 $5.15
Average True Range (ATR) 0.34 0.78
MACD -0.02 -0.06
Stochastic Oscillator 55.80 48.31

Price Performance

Historical Comparison
RSVR
YDES

About RSVR Reservoir Media Inc.

Reservoir Media Inc is an independent music company. The company operates a music publishing business, a recorded music business, a management business, and a rights management entity in the Middle East. The company's segments include Music Publishing and Recorded Music. It generates the maximum of its revenue from the U.S. Music Publishing segment engaged in the acquisition of interests in music catalogs to earn royalties and signing songwriters to agreements of future delivery of songs. The Recorded Music segment involve the acquisition of sound recording catalogs and the discovery and development of recording artists and the marketing, distribution, sale and licensing of the music catalog.

About YDES YD Bio Limited Ordinary Shares

YD Bio Ltd is a biopharmaceutical company focusing on blood-based cancer detection, the development of stem cell- and exosome-based therapeutics with the potential to transform the treatment of a wide spectrum of diseases with high unmet medical need and serving as a trusted supplier of clinical testing drugs for pharmaceutical companies. Stem cell therapy uses versatile cells to repair or regenerate damaged tissues, offering innovative treatments for injuries, degenerative diseases, and immune disorders with potential for personalized medicine and tissue engineering.

Share on Social Networks: